Skip to main content

Table 2 ATMP-CD133 production and delivery

From: Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133+ cells in ischemic refractory cardiomyopathy trial (RECARDIO)

Parameter

Value

BM harvest (ml)

349 ± 57

ATMP-CD133 production

 Cellularity (× 106)

6.57 ± 3.45

 Purity (%)

88.77 (86.30–90.75)

 Vitality (%)

99.90 (99.85–99.95)

ATMP-CD133 delivery

 Number of injections

12 (11–12)

 Procedural duration (min)

252 ± 91

 Mapping and injection time (min)

105 ± 29

 Fluoroscopy time (min)

63 ± 22

  1. Data presented as mean ± standard deviation or median (interquartile range), as appropriate
  2. ATMP advanced therapy medicinal product, BM bone marrow